A cannabis activist has filed a complaint against Good Day Farm, alleging that the company’s pricing practices hinder patient access to affordable medical marijuana. The activist contends that these practices contradict Good Day Farm’s mission of providing accessible medicinal solutions.
In December 2024, a cannabis activist filed a formal complaint against Good Day Farm, alleging unfair pricing practices in the medical marijuana market. The activist claims that Good Day Farm’s pricing strategies create barriers for patients seeking affordable access to medical cannabis.
Good Day Farm, a prominent player in the Southern U.S. cannabis industry, recently opened a flagship dispensary in Lake Charles, Louisiana. The company describes this facility as the largest of its kind in the South, offering a “Las Vegas-scale cannabis experience” .
The complaint alleges that Good Day Farm’s pricing structures are significantly higher than those of competitors, potentially limiting access for patients who rely on medical cannabis for treatment. The activist argues that such practices contradict the company’s stated mission to provide high-quality, accessible medicinal plant-based solutions.
This isn’t the first time Good Day Farm has faced legal scrutiny. In 2023, the company was involved in a lawsuit challenging state restrictions on medical marijuana advertising. The case highlighted tensions between cannabis businesses and regulatory bodies over marketing practices .
The recent complaint underscores ongoing challenges within the medical cannabis industry, particularly concerning pricing and patient access. As the sector continues to grow, balancing profitability with patient affordability remains a critical issue.
Good Day Farm has not publicly responded to the complaint at this time. The outcome of this case could have significant implications for pricing strategies and regulatory practices within the medical cannabis market.
